Abstract. Streptococcus iniae is a causative agent of hemorrhagic septicemia in olive flounder, Paralichthys olivaceus, in Korea, resulting in serious economic losses. As a preventive measure, M VAC INIAE (Mastuken, Japan) was prepared from the S. iniae F2K strain and tested against the SI-36 strain prevalent on flounder fish farms on Jeju Island, Korea. F2K had a serotype of 38 (-) and SI-36 38 (+). The vaccine recognized both serotypes. It showed a very high effective immune response against S. iniae; the challenge test using the S. iniae SI-36 strain resulted in a relative percent survival (RPS) of 85.7-87.0% 2 weeks after vaccination and 71.0-80.0% 6 months after vaccination. Field vaccination and clinical challenge tests were performed at local Jeju aquafarms with S. iniae SI-36. These showed significantly reduced cumulative mortality when compared to the control group with RPS rates that ranged between 71-80%. Hence, the present study suggests that this vaccine showed a significant immune response against S. iniae and could be applied in commercial aquafarms as a therapeutic agent against â-hemolytic streptococcosis in cultured P. olivaceus.
Introduction
Fish streptococcal infections have been considered to be one of the major problems associated with the worldwide intensification of aquaculture since 1970 (Baya et al. 1990 , Kitao 1993 , Agnew and Barnes 2007 . Among Streptococcus infections, Streptococcus iniae emerged as an important fish pathogen, which was first isolated from freshwater dolphins (Pier and Madin 1976) . It was reported that S. iniae is a causative agent of hemorrhagic septicemia that accompanies meningoencephalitis, exophthalmia, and corneal opacity in farmed fish (Roberts 2001) .
By 2012, Republic of Korea farmed flounder production accounted for 70% of the world's supply (Tveteras 2012) . Of this, 62% of production is derived from about 280 inland aquafarms. In Jeju Island alone, 24,575 mt of flounder were produced at farms covering a total of 100 ha of water. This has become one of the most important industries on this island (KOSIS 2012) . Intensification of culture is probably the cause of the enhanced propagation of bacterial, viral, and/or parasitic pathogens. In May 2005, flounder cultured in cage-culture systems on Jeju Island experienced high mortality rates with bilateral exopthalmic eyes and rotten gills (Baeck et al. 2006 , Jang et al. 2013 .
Previous reports on the bacterial diseases of cultured flounder that occurred in this area were associated with streptococcosis (Jung et al. 2004) , namely Streptococcos iniae and S. parauberis. Among them, S. iniae is reported to be a major fish pathogen in many regions of the world. The plasminogen binding property of the pathogenic S. iniae strain could suggest its virulence level, which could contribute to tissue invasion and overall pathogenicity (Boyle and Lottenberg 1997) . Hence, they are also zoonotic with infection in humans associated with handling and preparing infected fish (Weinstein et al. 1997) . According to Jeong et al. (2006) the infection rate of S. iniae in Jeju Island was 46% throughout 2003, and in 2005 it occurred throughout the year with high prevalence in the summer (Nguyen et al. 2002) . In particular, it was known that market size flounder over 30 cm in length were more susceptible to S. iniae, resulting in serious economic losses (Jeong et al. 2006) . A few studies have reported on a second serotype of S. iniae isolated from diseased fish from Israel and the USA (Bachrach et al. 2001 , Barnes et al. 2003a .
In general, the increased use of antibiotics in aquaculture has increased the resistance of S. iniae and prompted demands for an effective vaccine (Stoffregen et al. 1996 , Shoemaker et al. 2001 . Currently, several formalin-killed vaccines against â-hemolytic S. iniae strains are used in Korea (Cho et al. 2006 , Moon et al. 2007 , Shin et al. 2007 ). In particular, the â-hemolytic vaccine M VAC ININAE (Mastuken, Japan), which was developed with the S. iniae -F2K strain, is commercially available in Korea and Japan. The purpose of this study was to examine the chronic effect of serotypes of S. iniae in aquafarms located on Jeju, Korea in two clinical trials and to evaluate the efficacy, safety, and clinical administration of the S. iniae vaccine.
Material and methods

Bacterial strains and their characterization
The bacterial strains were isolated from pure cultures of infected olive flounder kidney and spleen, and they were also obtained from the Korean Collection for Type Cultures (KCTC). The strain F2K, used in the development of vaccine for S. iniae, was purchased from Mastuken, Japan. All bacterial strains were grown on Brain-Heart Infusion (BHI) agar (Difco, Grand Island, NY, USA) supplemented with 1.5% NaCl and 5% sheep blood (KOMED, Seoul, Korea) for 24-48 h at 25°C. Glycerol stocks of each isolated strain were prepared with 20% (v/v) glycerol in BHI broth (BD) and stored at -80°C. Isolates were cultured overnight at 20°C in BHI broth and Gram staining and motility tests were performed. General cell morphology was studied with phase contrast and scanning electron microscopy (SEM) according to standard procedures. Phenotypic characterization was carried out on all strains with an API 20E kit (BioMérieux) at 25°C, and the results were analyzed at 24 and 48 h. VITEC (BioMerieux) cards were also inoculated and allowed to incubate overnight for automated reading of reactions. Hemolysis tests were conducted in pure isolates using a 5% sheep blood agar plate (KOMED).
Vaccine preparation
The S. iniae vaccine was prepared with 10% neutrally-buffered formalin in a 0.3% solution on F2K strain cultures (1 × 10 7 CFU 100 ml -1 ), and this was used as the inactivated S. iniae vaccine according to the manufacturer's instructions (M VAC INIAE, Mastuken, Japan).
Preparation of rabbit antisera
Rabbit was immunized with intravenous injection of M VAC INIAE prepared from the S. iniae F2K strain, twice weekly in consecutive doses of 0.2, 0.4, 0.8, and 1.0 ml. One week after the last injection, the rabbit was bled from the ear vein. Two weeks later, this immunization procedure was repeated, now with 1.0 ml doses throughout. The antisera were stored at -20°C until use.
Slide agglutination test for S. iniae
The test was performed by mixing a small amount of each bacterial colony with several drops of 38 (-) or 38 (+) antiserum of the S. iniae (F2K) developed in rabbits.
Fish
About 500 healthy olive flounder (mean weight of 65.5 ± 0.13 g) were obtained from commercial fish farms on Jeju Island. The fish were habituated for two weeks in a 1.5-ton tank equipped with an ultraviolet sterilizer on a closed circulatory filter, and water temperature was maintained at 22 ± 1°C prior to the experiments. Throughout the immunogenicity and challenge experiments, the fish were held under standard culture conditions and fed twice a day with a commercial pelleted diet. The fish were confirmed to be negative for S. iniae infection by culturing fish tissue in BHI agar (BD, USA).
Immunogenicity test
For the immunogenicity test, 500 olive flounder were selected that had not been previously exposed to antibiotics and with no traces of the S. iniae antibody. For vaccine inoculation, all fish were anesthetized by immersion in a tank containing 150 mg l -1 of tricaine methanesulfonate for 15 min and divided into two groups (n = 125, in duplicate) -the control and vaccinated groups -and each group of fish received either 100 µl of phosphate-buffered saline (PBS: 0.2 M monobasic phosphate, 0.2 M dibasic phosphate, 0.11 M sodium chloride, pH 7.4) or the vaccine intraperitoneally. To test antibody formation, serum was extracted from the tail vein of 10 fish from each PBS and vaccine-treated group starting 2 weeks after vaccination and up to 9 weeks after vaccination. The serum obtained was used for the agglutination assay (Yildirim et al. 2003) . Briefly, 50 ìL of serum was serially diluted in a 96-well microplate with 50 ìL of PBS. After this, 50 ìL of vaccine was added to each well as an antigen and incubated in a humidified chamber at 25°C for 24 h. Agglutination titers were expressed as log2 (x+1) of the reciprocal of the highest serum dilution showing visible agglutination as compared to the positive control. The last well, in which there was only 50 mL PBS buffer, was the negative control.
Challenge experiment
For the challenge test, after two weeks of vaccination, forty fish from each vaccinated and control fish groups were injected intraperitoneally with 100 µl of the challenge strain S. iniae-SI-36, (1 × 10 7 CFU ml -1 , LD 70 ) and PBS, respectively. Mortalities were recorded for 2 weeks, and any clinical symptoms in survivors were noted. The cause of death and pathological symptoms were confirmed by re-isolating bacteria from kidney samples of freshly dead fish or survivors. Cumulative mortality was registered and relative percent survival (RPS) was calculated according to the formula: RPS (%) = [1 -(cumulative mortality of the vaccine-treated group/cumulative mortality of the PBS-treated group)] × 100. The vaccine was found to be efficient if the relative percent survival (RPS) rate of the vaccine-treated group was more than 60% when compared to that of PBS-treated group (Amend 1981) .
First clinical trial of the vaccine at aquafarms
Vaccine efficacy was tested at five aquafarms located on the northeast (aquafarm A) and southeast (aquafarms B, C, D and E) coasts of Jeju Island (Fig. 
). All farms have been practicing flounder culture for more than a decade. At each of the aquafarms, four culture ponds (two control and two vaccinated fish groups) with numbers of fish ranging from 5,700 to 10,000 and with average body weights of about 150.1 ± 0.2 g were selected. All fish in the vaccinated ponds were injected with vaccine as previously mentioned. Growth and the natural infection pattern of S. iniae were monitored for 20 ± 2 weeks at all the aquafarms. Necropsies were performed on all of the dead fish that exhibited â-hemolytic streptococcosis symptoms to determine whether they were infected with Streptococcus. Multiplex PCR diagnosis for S. iniae was also carried out according to Mata et al. (2004) .
Second clinical trial of the vaccine at aquafarms
A second clinical trial was performed to assess the chronic efficiency of the vaccine six months after vaccination. For this, fish from aquafarms B and C were transported to the Marine Research Institute of Jeju National University, and acclimated for 4 weeks in a 1.5-ton FRP water tank equipped with an ultraviolet sterilizer in a closed circulatory filter. At the beginning of the experiment the average fish weight ranged from 410 to 700 g. In the challenge test, 100 µl (1 × 10 7 CFU ml -1
; LD 70 ) of SI-36 strain was injected intraperitoneally and cumulative mortality was recorded for the following 2 weeks. Vaccine efficiency was calculated by obtaining the RPS rate of both the control and vaccinated challenged fish groups. All dead fish were examined for the presence of S. iniae and S. parauberis using the multiplex PCR method.
Statistical data analysis
All data were analyzed using one-way ANOVA to test the effects of the vaccine among vaccinated and non-treated groups. A t-test was performed using SAS statistical software (SAS Institute, Cary, NC, USA).
Results and discussion
The isolates were strictly anaerobic, Gram-positive, sphere-shaped bacteria (Fig. 2 ) that grew at 37°C. The phenotypic characteristics of Streptococcus spp., including strains obtained from the Korean Collection for Type Cultures and the isolates from diseased fish, are listed in Table 1 . Among the different strains, the F2K strain used in the production of the vaccine against S. iniae was compared to known KCTC-3657 and SI-36 (wild-type) strains. According to the comparison, the F2K strain showed a high similarity to the phenotypic characteristics of S. iniae and was distinguishable from S. parauberis. However, the F2K strain showed negative reactions to arginine dihydrolase, alkaline phosphatase, and pyrroidonyl arylamidase, unlike the KCTC-3657 and SI-36 strains. Therefore, the F2K strain demonstrated a different phenotypic polymorphism than that of general S. iniae.
Recent studies proposed that bacterial success is influenced by serotypic variation (Klesius et al. 2000, Agnewa and Barnes 2007) . In the present study, serological identification using S. iniae with antisera 38 (-) and 38 (+) was performed on S. parauberis strains (KCTC-3651 and SP-5) and S. iniae strains (F2K, KCTC-3657, SI-4 and SI-36). The results indicated that no coagulated reactions were found with any S. parauberis strains, while the S. iniae strains, such as KCTC-3657, SI-4, and SI-36, showed signs of agglutination in all 38 (-) and 38 (+) antisera, and were assigned to serotype 38 (+) ( Table 2 ). On the other hand, strain F2K showed signs of agglutination only with the 38 (-) type antiserum; hence, it was assigned to serotype 38 (-). These results support the existence of two serotypes in S. iniae; the serological characters of the F2K strain indicate that it retained both 38 (-) and 38 (+)-type-specific antigens. The phenotypic polymorphism results showed that the F2K strain had many similarities to S. iniae serotype II, which has extremely high pathogenicity with negative arginine dehydrolase activity (Bachrach et al. 2001 , Barnes et al. 2003a , Zlotkin et al. 2003 . According to these studies, serotype I responded to both serotypes I and II antisera, but serotype II showed agglutination activity only with serotype II antiserum. An experiment on the removal of cell-surface protein components suggested that the antigenic determinant could only exist in serotype II, which may not be a capsule component, and, therefore, it could be a cell-surface protein (Barnes et al. 2003b ). Accordingly, the high similarity of biochemical tests between the F2K and AD type strains (Barnes et al. 2003a) suggests that the F2K strain could be the same serotype as serotype II since it retains both serotype I and II antigens. Therefore, F2K is an important strain to consider when making a vaccine because the strain has a cross-reactivity to both serotypes: the 38 (-) and 38 (+) strains.
In the immunogenicity test against S. iniae (F2K) the agglutination titer rapidly increased from 2 2.7 to 2 4 from week 2 to 4 two weeks after the vaccination 28 Yong-Uk Jeong et al. treatment, reaching a maximum of 2 4.6 at week 8, and then declining to 2 4.5 at week 9 post-vaccination (Fig. 3) . These results indicate that the immune system of the olive flounder generate the specific antibody and has positive immunogenicity against S. iniae (F2K). The practical protection effect was determined through challenge tests, which were performed twice 2 weeks after vaccination. Fish that had been artificially infected with S-36 started to die on the fourth day after injection and presented typical signs of Streptococcus infection, such as exophthalmia (pop-eye), hemorrhaging in the eye, ascitic fluid in the intra-peritoneal cavity, and a darkened surface. Furthermore, the cumulative mortality rates of PBS-treated groups 1 and 2 were 76.7 and 70.0%, respectively, while the cumulative mortality rate of vaccine-treated groups 1 and 2 was only 10.0% (Table  3) . Mortality of fish in the control groups initiated from 4-5% at day 4 then sharply increased to about 60% on day 7, while in the vaccine treated groups it was less than 10% during the same period (Fig. 4) . The efficiencies of the vaccine (RPS) in groups 1 and 2 were 87.0 and 85.7%, respectively (Table 3) . The protection results suggest that single administration of the vaccine showed similar efficacies to the results Moon et al. (2007) and Cho et al. (2006) reported regarding testing the efficacies of vaccines against S. iniae. Culture re-isolation of the challenge strain confirmed that the fish were infected by the challenged strain and not by other pathogenic fish bacteria (data not shown). Therefore, the vaccine challenge test results indicated that fish can develop specific antibodies against S. iniae (SI-36) when the vaccine was administered to P. olivaceus.
The results of clinical trials carried out in five flounder aquafarms on Jeju Island using the S. iniae vaccine are illustrated in Table 4 . The average weights of the fish in each clinical trial ranged from 125 to 176 g, and the evaluation group had approximately 5,600 to 10,000 fish. However, no effect of the vaccine was observed at any of the aquafarms. At each aquafarm, cumulative mortality ranged from 5 to 38% depending on the aquafarm and with no difference between the vaccinated and control groups. It is believed that the main reason the vaccine had no effect is attributed to the very low occurrence of S. iniae during the experiment. Indeed, the multiplex PCR assay designed to detect S. iniae and S. parauberis showed that S. iniae were diagnosed in only 3 and 4 vaccinated fish at aquafarms B and C, respectively. In the control group, only 1 dead fish showed S. iniae infection at aquafarm C. In contrast to S. iniae infection, high prevalence of S. parauberis was noted at all aquafarms during the experiment, suggesting that the vaccine does not have a protective effect against S. parauberis. Therefore, the efficacy of the vaccine M VAC INIAE was not consistent at all aquafarms as high levels of other bacterial and parasitic diseases such as edwardsiellosis, vibriosis, flexibacteriosis, and scuticociliatosis were also causative agents of dead fish at the aquafarms (Table 4) . Due to low prevalence of S. iniae at the aquafarms, more than 200 fish immunized or non-treated at aquafarms B and C, respectively, were challenged with S. iniae (SI-36) 6 months after vaccination and monitored for mortality rates and RPS for a 2-week period (Table 5) . During the experiment, the non-treated fish group started to die on the sixth day after injection at both aquafarms, showing typical symptoms of streptococcosis, with exophthalmia, hemorrhaging in the eye, ascitic fluid in the intraperitoneal cavity, and a darkened surface. The cumulative mortalities of the vaccinated and non-treated groups at aquafarm B were 15.0 and 75.0%, respectively. Similarly, at aquafarm C cumulative mortality rates in the test and control groups were 19.2 and 66.0%, respectively. RPS rates were 80% at aquafarm B and 71% at aquafarm C. Re-isolating the challenge strain in dead fish confirmed that the vaccine could be a homogeneous strain. More than 80% of dead fish showed typical symptoms of streptococcosis in the control group, while vaccinated fish exhibited only a 20% mortality rate caused by disease in each aquarium (data not shown).
Hence, the results of this study permit concluding that the vaccine M VAC INIAE has a protective effect on the wild type S. iniae (SI-36) in olive flounders on Jeju, and immunity against S. iniae lasted for at least 6 months. However, the application of the vaccine to control S. iniae in the olive flounder on Jeju should be done based on the prevalence of the disease. 
